Shundong Cang Selected Research

Shundong Cang Research Topics

Disease

24	Neoplasms (Cancer) 02/2024 - 06/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 04/2016
8	Disease Progression 02/2024 - 01/2021
6	Adenocarcinoma 12/2023 - 12/2009
6	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 12/2009
4	Melanoma (Melanoma, Malignant) 11/2023 - 09/2020
4	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2013
3	Adenocarcinoma of Lung 02/2024 - 09/2021
3	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 12/2023 - 10/2020
3	Carcinogenesis 01/2020 - 10/2014
2	Triple Negative Breast Neoplasms 04/2024 - 01/2024
2	Esophageal Squamous Cell Carcinoma 02/2024 - 01/2022
2	Glioma (Gliomas) 06/2023 - 09/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2019
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2010 - 06/2009
1	Microsatellite Instability 12/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2023
1	Anemia 12/2023
1	Neuroblastoma 12/2022
1	Neoplasm Micrometastasis 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Ductal Carcinoma 01/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hyperkalemia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Liver Failure 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Intestinal Volvulus (Volvulus) 01/2021
1	Hypoxia (Hypoxemia) 09/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2021
5	sintilimabIBA 12/2023 - 01/2021
4	Long Noncoding RNAIBA 02/2024 - 11/2019
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 07/2021
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 04/2016
4	phenethyl isothiocyanate (PEITC)IBA 01/2020 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 10/2014
3	Biosimilar PharmaceuticalsIBA 01/2023 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2021
3	camrelizumabIBA 06/2022 - 01/2022
3	PlatinumIBA 01/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	MicroRNAs (MicroRNA)IBA 07/2021 - 01/2018
3	Histones (Histone)IBA 01/2020 - 12/2009
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 12/2009
2	CrizotinibIBA 02/2024 - 01/2023
2	ensartinibIBA 02/2024 - 01/2021
2	toripalimabIBA 01/2024 - 01/2022
2	Docetaxel (Taxotere)FDA Link 09/2023 - 01/2023
2	Messenger RNA (mRNA)IBA 06/2023 - 09/2020
2	rezivertinibIBA 01/2023 - 11/2022
2	Pemetrexed (MTA)FDA Link 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2010
2	apatinibIBA 12/2022 - 06/2022
2	Monoclonal AntibodiesIBA 01/2022 - 10/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2015
2	AndrogensIBA 01/2020 - 05/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2019 - 10/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2014 - 02/2013
2	Histone Deacetylase InhibitorsIBA 02/2010 - 06/2009
2	Vorinostat FDA Link 02/2010 - 06/2009
1	Anaplastic Lymphoma KinaseIBA 02/2024
1	VimentinIBA 02/2024
1	sugemalimabIBA 02/2024
1	130-nm albumin-bound paclitaxelIBA 01/2024
1	icotinibIBA 10/2023
1	Therapeutic UsesIBA 09/2023
1	Firefly LuciferasesIBA 06/2023
1	Caspase 3 (Caspase-3)IBA 06/2023
1	cabazitaxel FDA Link 01/2023
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 12/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 09/2021
1	6-methyladenineIBA 07/2021
1	Circulating Tumor DNAIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Fetal Proteins (Fetoprotein)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Capsaicin (Zostrix)FDA Link 10/2020
1	Glycoproteins (Glycoprotein)IBA 09/2020
1	IgA receptor (protein B)IBA 09/2020
1	Circular RNAIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CollagenIBA 12/2019
1	Thyroid HormonesIBA 12/2019

Therapy/Procedure

17	Therapeutics 12/2023 - 06/2009
12	Drug Therapy (Chemotherapy) 02/2024 - 11/2015
2	Immunotherapy 01/2023 - 09/2021
1	Radiotherapy 12/2023
1	Castration 01/2023
1	Adjuvant Radiotherapy 01/2022
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022